Alpha-gal syndrome cases rise with lone star tick range expansion into northern states

Next steps require prospective cohort studies that pair seroconversion rates with standardized tick-exposure metrics and climate covariates across latitudinal gradients. Such designs would clarify whether the observed increase is primarily climatic or diagnostic. Regulatory tracking of the new monoclonal therapy should include geographic utilization data to test whether treatment access tracks the expanding risk zone.